Wolverine Asset Management’s Bellevue Life Sciences Acquisition Corp. Rights BLACR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-121,585
| Closed | -$15.8K | – | 1484 |
|
|
2024
Q4 | $15.8K | Hold |
121,585
| – | – | ﹤0.01% | 907 |
|
|
2024
Q3 | $13.3K | Hold |
121,585
| – | – | ﹤0.01% | 881 |
|
|
2024
Q2 | $12.2K | Hold |
121,585
| – | – | ﹤0.01% | 907 |
|
|
2024
Q1 | $18.2K | Hold |
121,585
| – | – | ﹤0.01% | 844 |
|
|
2023
Q4 | $18.2K | Hold |
121,585
| – | – | ﹤0.01% | 921 |
|
|
2023
Q3 | $28K | Hold |
121,585
| – | – | ﹤0.01% | 933 |
|
|
2023
Q2 | $23.2K | Hold |
121,585
| – | – | ﹤0.01% | 903 |
|
|
2023
Q1 | $21.9K | Buy |
+121,585
| New | +$21.9K | ﹤0.01% | 998 |
|